Currently, no Treg-based therapies are approved. The regulatory T-cells (Tregs) sector across the seven major markets (7MM) ...

Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of multiple joints, with regulatory T (Treg) ...

Rheumatoid arthritis is an autoimmune disease that is ... antigen-presenting cells selectively target and suppress activated T cells while sparing naive T cells, preventing autoimmune disease ...

Based on clinical trial data, abatacept was not associated with increased malignancy risks in RA or PsA; observational data indicated a higher risk vs other b/tsDMARDs.

Opens in a new tab or window In general, rheumatoid arthritis and higher BMI each increase ... The researchers weren't sure how to account for these latter findings. They may be "potentially ...

Clinical and Radiographic Outcomes of Four Different Treatment Strategies in Patients With Early Rheumatoid Arthritis (the Best Study): A Randomized, Controlled Trialfrom Arthritis & Rheumatism.

Fan Zhang, PhD, sees artificial intelligence as a pathway to finding an effective way to combat an intractable enemy: rheumatoid arthritis ... expansion of specific T cell subtypes, in the ...

Rheumatoid arthritis (RA) and lupus both cause joint ... triggering inflammation and damaging healthy tissue. Experts aren’t sure of all the triggers of autoimmune diseases, but they can run ...

Hemoglobin is a protective factor against C-reactive protein in rheumatoid arthritis, potentially slowing ... mean corpuscular Hb, and red cell distribution width (P < .05). To better investigate ...

Dr. Cush is an authority in rheumatology, specializing in rheumatoid arthritis, spondyloarthropathies, and drug safety. He has authored more than 150 scientific publications, including two ...